Picture of Kuros Biosciences AG logo

KURN — Kuros Biosciences AG News Story

0.000.00%
ch flag iconLast trade - 00:00
HealthcareHighly SpeculativeMid CapMomentum Trap

Brief: Kuros Biosciences H1 Net Loss At CHF 5.2 Million

Aug 20 (Reuters) - Kuros Biosciences AG  KURN.S :
    * PRODUCT SALES WERE CHF 0.9 MILLION IN FIRST HALF OF 2019,
A
SUBSTANTIAL INCREASE COMPARED TO H1 2018
    * OTHER INCOME IN FIRST HALF OF 2019 AND 2018 WAS CHF 0.2
MILLION
AND CHF 1.1 MILLION RESPECTIVELY
    * NET LOSS AS PER JUNE 30, 2019 AMOUNTS TO CHF 5.2 MILLION
AND
REMAINS UNCHANGED COMPARED TO CORRESPONDING PERIOD IN FIRST HALF
OF 2018.
    * EXPECTS A FURTHER ACCELERATION FOR REMAINDER OF 2019.

Source text for Eikon:  ID:nTEN31qlsa 
Further company coverage:  KURN.S 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on Kuros Biosciences AG

See all news